SCHEMBL1084006

SCHEMBL1084006

CCc1ccccc1-c1nc(Nc2n[nH]c3ccccc23)c2ccccc2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP1 O94782 1/20 0.53
WDR48 Q8TAF3 1/20 0.53
CYP1A2 P05177 13/20 0.50
CYP3A4 P08684 12/20 0.50
CYP2D6 P10635 11/20 0.50
TSHR P16473 9/20 0.50
LMNA P02545 5/20 0.50
USP2 O75604 3/20 0.50
CYP2C19 P33261 4/20 0.46
ALOX15 P16050 4/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPK1 P28482 3/20 0.44
HSD17B10 Q99714 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802127 0.89 CYP1A2 (0.48) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL14393588 0.89 CYP1A2 (0.48) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL1083862 0.89 USP1 (0.48) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL13107395 0.88 CYP1A2 (0.47) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL785479 0.84 CYP1A2 (0.61) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL801910 0.83 FADS1 (0.47) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL801930 0.82 MEN1 (0.45) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL786005 0.82 CYP1A2 (0.60) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL10266745 0.82 MEN1 (0.45) USP1WDR48CYP1A2CYP3A4CYP2D6
SCHEMBL801927 0.82 MEN1 (0.64) LMNAALDH1A1MAPK1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed